Login to Your Account

Burrill Capital Fund IV Takes on Foreign Flavor

By Marie Powers
Staff Writer

Tuesday, January 17, 2012
SAN FRANCISCO – Although most of the biotech world is starting the week with a J.P. Morgan Healthcare Conference hangover, it's business as usual for the redoubtable Steve Burrill, whose life sciences venture firm, Burrill & Co., recently added Capital Fund IV to its portfolio.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription